Polymorphism of lncRNAs in breast cancer: Meta-analysis shows no association with susceptibility
- PMID: 32889751
- DOI: 10.1002/jgm.3271
Polymorphism of lncRNAs in breast cancer: Meta-analysis shows no association with susceptibility
Abstract
Background: Long non-coding RNAs (lncRNAs) have been the target of considerable attention for their roles in many biological processes. Only a small portion of lncRNAs are functionally characterized, and several approaches have been proposed for investigating the roles of these molecules, including how polymorphisms in lncRNA genomic sites may interfere with their function. Allele frequency variation in single nucleotide polymorphisms (SNPs), for example, has been associated with several diseases, including breast cancer (BC), the most common type of cancer in women.
Methods: In the present study, we performed a systematic review of lncRNA SNPs associated with BC and a meta-analysis of some lncRNA SNPs. We found 31 SNPs mapped in 12 lncRNAs associated with BC in 28 case-control studies.
Results: Our meta-analysis showed an insignificant difference between the SNPs rs217727, rs3741219, rs2107425 and rs2839698 on H19, as well as rs920778, rs1899663, rs12826786 and rs4759314 on HOTAIR, and BC susceptibility.
Conclusions: The present analysis recognized the importance of extensive association studies, including different populations, and further evaluation of potential functional effects caused by lncRNA SNPs. Nevertheless, genetic variants such as SNPs in lncRNAs may play many other essential roles, although this field is still under explored.
Keywords: H19; HOTAIR; SNP; breast cancer; lncRNA.
© 2020 John Wiley & Sons, Ltd.
References
REFERENCES
-
- Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study global burden. JAMA Oncol. 2017;3:524-548.
-
- Pondé NF, Zardavas D, Piccart M. Progress in adjuvant systemic therapy for breast cancer. Nat Rev Clin Oncol. 2019;16:27-44.
-
- Li N, Deng Y, Zhou L, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of disease study 2017. J Hematol Oncol. 2019;12:140-152.
-
- Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253-1261.
-
- Pang B, Wang Q, Ning S, et al. Landscape of tumor suppressor long noncoding RNAs in breast cancer. J Exp Clin Cancer Res. 2019;38:1-18.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
